{
    "nctId": "NCT01239251",
    "briefTitle": "GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy",
    "officialTitle": "Feasibility of Using the GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 8,
    "primaryOutcomeMeasure": "Assess the usability of the GlowCap system by patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen, anastrozole, letrozole, exemestane).\n* Age \u2265 60 years\n* Must have broadband internet access at home (to enable the base for the system to communicate to the Vitality server).\n* Must have a landline or mobile phone\n\nExclusion Criteria:\n\n* Non-English speaking patients",
    "sex": "FEMALE",
    "minimumAge": "60 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}